Insurance giant takes aim at weight-loss drug prices, saying cost will limit adoption
UnitedHealth Group Inc. UNH, +2.16% posted better-than-expected earnings for the third quarter on Friday and again raised its full-year guidance.
The company raised its full-year adjusted earnings guidance to a range of $24.85 to $25.00 per share, compared with a FactSet consensus of $24.83. On a call with analysts Friday, UnitedHealth faced several questions about coverage of popular diabetes and weight-loss drugs such as Ozempic and Wegovy. “We’re struggling, and frankly our clients are struggling, with the list prices which have been demanded on these products in the U.S.,” UnitedHealth CEO Andrew Witty said on the call.
Even as the executives were speaking, Novo Nordisk NVO, +2.15% boosted its full-year 2023 profit and sales outlook, citing heightened expectations for Ozempic and Wegovy sales.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
UnitedHealth Q3 earnings beat estimates as company again raises guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Weiterlesen »
UnitedHealth Group Profits Top $5.8 Billion On ‘Double-Digit’ Optum And Health Plan GrowthI've written about health care for three decades, starting from my native Iowa where I covered the presidential campaign bus rides of Bill and Hillary Clinton through the Hawkeye state talking health reform and the economy.
Weiterlesen »
UnitedHealth beats quarterly profit estimates on easing medical costsUnitedHealth beats quarterly profit estimates on easing medical costs
Weiterlesen »
UnitedHealth higher after Q3 earnings beat, 2023 profit outlook boostDow component UnitedHealth topped third quarter earnings forecasts and lifted the lower-end of its prior forecast for full-year profits.
Weiterlesen »
UnitedHealth profit beats on lower-than-feared medical costsUnitedHealth (UNH.N) reported a third-quarter profit on Friday ahead of analysts' estimates, helped by a lower-than-feared rise in medical costs at the company's health insurance unit.
Weiterlesen »
Stocks slip lower, JPMorgan, UnitedHealth, Wells Fargo earnings in focus, Oil surgesStocks lower, JPMorgan, UnitedHealth, Wells Fargo, Oil surge
Weiterlesen »